Science to Consumers, Inc.

Science to Consumers, Inc.

BEUT
Science to Consumers, Inc.US flagOther OTC
0.00
USD
- -
- -
3,192.00Market Cap
2013 Y
2014 Y
2015 Y
2016 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
26
30
31
32
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
May'16
Aug'17
Nov'17
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
32
32
32
Market Capitalization
44
37
45

Working Capital

FRC

in mil. unless spec.
May'16
Aug'17
Nov'17
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
637.85%
Free Cash Flow
- -
- -
-2.86%
Net Income, GAAP
- -
- -
19.57%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2015
- -
- -
- -
- -
- -
2016
- -
- -
- -
- -
- -
2017
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2015
- -
- -
- -
- -
- -
2016
- -
- -
- -
- -
- -
2017
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2015
- -
- -
- -
- -
- -
2016
- -
- -
- -
- -
- -
2017
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Ensley Edwon Lam
Full Time Employees
1
Sector
Consumer Defensive
Industry
Household & Personal Products
Address
20 W. Park Avenue, Suite 207 Long Beach NY United States of America 11561
IPO Date
Jul 21, 2014
Business
Science to Consumers, Inc. operates as a development stage company primarily engaged in the marketing and selling of formulated anti-aging skincare products under the DermaLastyl brand, including items such as Dermalastyl Facial Scrub, Dermalastyl Bx Pro, Dermalastyl Bx Elastropin, Dermalastyl-e Intensive Eye Serum, Dermalastyl-m Wrinkle Eye Radicator, and Dermalastyl-m Anti-Wrinkle After-Shave for Men. The company also distributes Argan oil products targeting both individual consumers and commercial customers such as spas, retail stores, and massage therapy offices. Founded in 2013 and headquartered in Guangzhou, China, Science to Consumers, Inc. was formerly known as Argan Beauty Corporation until it rebranded to its current name in December 2014. The company operates primarily in the consumer staples sector within the household and personal products industry. Recent public information does not indicate major acquisitions, funding rounds, or partnerships in the last one to two years, and the company continues to focus on expanding its anti-aging and personal care product portfolio with an emphasis on its DermaLastyl line.